Summary
This 8-K filing from CVS Health Corporation reports the voting results from its Annual Meeting of Stockholders held on May 16, 2019. The meeting confirmed the election of all 16 nominated directors for a one-year term. Additionally, stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2019 and approved, on a non-binding advisory basis, the compensation of the named executive officers. A previously proposed stockholder resolution concerning executive compensation metrics was withdrawn and not voted upon.
Key Highlights
- 116 directors were elected to the Board of Directors for one-year terms.
- 2The appointment of Ernst & Young LLP as the independent auditor for 2019 was ratified.
- 3Stockholders approved, by a non-binding vote, the compensation of named executive officers.
- 4A significant number of shares (1,149,426,293) constituted a quorum for the meeting.
- 5All director nominees received a substantial majority of 'For' votes, indicating strong support.
- 6The proposal regarding executive compensation had the highest number of 'Against' votes among the approved company proposals, though still passed.
- 7A stockholder proposal related to executive compensation was withdrawn prior to the meeting.